http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-9401045-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 |
filingDate | 1994-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d48fb4cf5197ea8b94abf082e4c899d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1788c159e441aa223c801994aec1286e |
publicationDate | 1995-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NL-9401045-A |
titleOfInvention | New use of growth hormone. |
abstract | The invention relates to a novel use of growth hormone wherein growth hormone, for example recombinant growth hormone, preferably human recombinant growth hormone, is used to prepare a pharmaceutical preparation to treat patients having a low triiodothyronine level. A low triiodothyronine can be due to the low-T3 syndrome as described in the literature. The low-T3 syndrome in a patient can be caused by a large number of clinical conditions, which can be both physical and psychological (mental). The use of medicaments likewise can cause the low-T3 syndrome. According to the invention it is possible for one or more thyroid hormones and/or anabolic steroids to be administered at the same time as growth hormone. |
priorityDate | 1994-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 255.